Invesco’s Takeda Pharmaceutical TAK Stock Holding History

Invesco’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Sell	15,000 -3,485	-19%	-$57.7K	﹤0.01%	3524
2026 Q1	$342K	Buy	+18,485	New	+$324K	﹤0.01%	3294
2025 Q3	–	Sell	-35,977	Closed	-$556K	–	3856
2025 Q2	$556K	Sell	35,977 -13,970	-28%	-$206K	﹤0.01%	3113
2025 Q1	$743K	Buy	+49,947	New	+$700K	﹤0.01%	2968
2023 Q2	–	Sell	-43,710	Closed	-$720K	–	3942
2023 Q1	$720K	Buy	+43,710	New	+$696K	﹤0.01%	3070
2022 Q4	–	Sell	-33,601	Closed	-$436K	–	4064
2022 Q3	$436K	Sell	33,601 -11,658	-26%	-$162K	﹤0.01%	3320
2022 Q2	$635K	Sell	45,259 -4,806	-10%	-$68.6K	﹤0.01%	3217
2022 Q1	$717K	Buy	+50,065	New	+$735K	﹤0.01%	3228
2019 Q4	–	Sell	-64,209	Closed	-$1.1M	–	3698
2019 Q3	$1.1M	Sell	64,209 -1,934	-3%	-$33.4K	﹤0.01%	2945
2019 Q2	$1.17M	Sell	66,143 -3,414	-5%	-$62.1K	﹤0.01%	2984
2019 Q1	$1.42M	Buy	+69,557	New	+$1.4M	﹤0.01%	2821

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Invesco's TAK Position: Q2 2026 in Review

Invesco reduced its Takeda Pharmaceutical (TAK) stake by 19% in Q2 2026, selling an estimated $57.7K and leaving 15,000 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #3524.

Invesco first reported a position in TAK in Q1 2019 and has held it in 11 quarters since. The position peaked at $1.42M in Q1 2019. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Invesco held 15,000 shares of Takeda Pharmaceutical worth $240K as of Q2 2026.
Invesco sold 3,485 Takeda Pharmaceutical shares in Q2 2026, an estimated $57.7K.
Takeda Pharmaceutical made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3524 holding.
Invesco first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 11 quarters since.
Invesco's Takeda Pharmaceutical position peaked at $1.42M in Q1 2019.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.